Horizon 2020 Szechenyi 2020
CLOSE Return to home page Highly Efficacious

Inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis is a chronic inflammatory disease with gastrointestinal signs and symptoms. The disease often leads to loss of body weight, and gastrointestinal complications that have a deleterious effect on the patient’s nutritional status. If the gut can be used safely, enteral nutrition is the preferred feeding method for patients with IBD. The advantages of enteral nutrition include its stimulatory effects on the gastrointestinal structure and function as well as its reduced cost compared to parenteral feeding. However, the oral nutritional supplements used for the nutrition of IBD patients need to be adapted to the altered nutritional needs of the patients originating from the chronic inflammation, loss of body weight and lean body mass, and damage to the bowel mucosa.

Our product in development is addressing these nutritional needs.


Clinical research of the past decade has shown that specific conditions require specific medical nutrition. According to these scientific findings and based on an approach focusing on patients and conditions we are currently working to identify the specific nutritional needs of many different illnesses in order to develop products which address these needs. 

To read more about our development strategy and on-going research, click here.